Experimental Hematology
Volume 38, Issue 5 , Pages 373-383 , May 2010

Heterogeneous expression and function of IL-21R and susceptibility to IL-21−mediated apoptosis in follicular lymphoma cells

  • Daniela de Totero

      Affiliations

    • Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy
    • Drs. de Totero and Capaia contributed equally to this work.
    • ,
  • Matteo Capaia

      Affiliations

    • Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy
    • Drs. de Totero and Capaia contributed equally to this work.
    • ,
  • Marina Fabbi

      Affiliations

    • Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy
    • ,
  • Michela Croce

      Affiliations

    • Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy
    • ,
  • Raffaella Meazza

      Affiliations

    • Istituto G. Gaslini, Genoa, Italy
    • ,
  • Giovanna Cutrona

      Affiliations

    • Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy
    • ,
  • Simona Zupo

      Affiliations

    • Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy
    • ,
  • Fabrizio Loiacono

      Affiliations

    • Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy
    • ,
  • Mauro Truini

      Affiliations

    • Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy
    • ,
  • Manlio Ferrarini

      Affiliations

    • Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy
    • DOBIG, University of Genoa, Genoa, Italy
    • ,
  • Silvano Ferrini

      Affiliations

    • Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy
    • Corresponding Author InformationOffprint requests to: Silvano Ferrini, M.D., CBA, Istituto Nazionale per la Ricerca sul Cancro, Largo Benzi 10, 16132 Genova, Italy

Received 26 May 2009 ,Revised 18 February 2010 ,Accepted 22 February 2010.

References 

  1. Spolski R, Leonard WJ. Interleukin-21: basic biology and implications for cancer and autoimmunity. [review] Ann Rev Immunol. 2008;26:57–79
  2. Asao H, Okuyama C, Kumaki S, et al. Cutting edge: the common gamma-chain is an indispensable subunit of the IL21 receptor complex. J Immunol. 2001;167:1–5
  3. Zeng R, Spolski R, Casas E, Zhu W, Levy DE, Leonard WJ. The molecular basis of IL21-mediated proliferation. Blood. 2007;109:4135–4142
  4. de Totero D, Meazza R, Capaia M, et al. The opposite effects of IL-15 and IL21 on CLL B cells correlate with differential activation of the JAK/STAT and ERK1/2 pathways. Blood. 2008;111:517–524
  5. Ozaki K, Spolski R, Feng CG, et al. A critical role for IL21 in regulating immunoglobulin production. Science. 2002;298:1630–1634
  6. Konforte D, Simard N, Paige CJ. IL21: an executor of B cell fate. J Immunol. 2009;182:1781–1787
  7. Di Carlo E, de Totero D, Piazza T, Fabbi M, Ferrini S. Role of IL21 in immune-regulation and tumor immunotherapy. Cancer Immunol Immunother. 2007;56:1323–1334
  8. Roda JM, Parihar R, Lehman A, Mani A, Tridandapani S, Carson WE. Interleukin-21 enhances NK cell activation in response to antibody-coated targets. J Immunol. 2006;177:120–129
  9. Ueda M, Imada K, Imura A, Koga H, Hishizawa M, Uchiyama T. Expression of functional interleukin-21 receptor on adult T-cell leukaemia cells. Br J Haematol. 2005;128:169–176
  10. Brenne AT, Baade Ro T, Waage A, Sundan A, Borset M, Hjorth-Hansen H. Interleukin-21 is a growth and survival factor for human myeloma cells. Blood. 2002;99:3756–3762
  11. Scheeren FA, Diehl SA, Smit LA, et al. IL21 is expressed in Hodgkin lymphoma and activates STAT5: evidence that activated STAT5 is required for Hodgkin lymphomagenesis. Blood. 2008;111:4706–4715
  12. de Totero D, Meazza R, Zupo S, et al. Interleukin-21 receptor (IL21R) is up-regulated by CD40 triggering and mediates proapoptotic signals in chronic lymphocytic leukemia B cells. Blood. 2006;107:3708–3715
  13. Jahrsdorfer B, Blackwell SE, Wooldridge JE, et al. B-chronic lymphocytic leukemia cells and other B cells can produce granzyme B and gain cytotoxic potential after interleukin-21-based activation. Blood. 2006;108:2712–2719
  14. Gowda A, Roda J, Hussain SR, et al. IL21 mediates apoptosis through up-regulation of the BH3 family member BIM and enhances both direct and antibody-dependent cellular cytotoxicity in primary chronic lymphocytic leukemia cells in vitro. Blood. 2008;111:4723–4730
  15. Akamatsu N, Yamada Y, Hasegawa H, et al. High IL21 receptor expression and apoptosis induction by IL21 in follicular lymphoma. Cancer Lett. 2007;256:196–206
  16. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994;84:1361–1392
  17. Harris N, Jaffe E, Diebold J, et al. World Health Organization classification of neoplastic diseases of the hematomoietic and lymphoid tissues: report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. J Clin Oncol. 1999;17:3835–3849
  18. Meazza R, Basso S, Gaggero A, et al. Interleukin (IL)-15 induces survival and proliferation of the growth factor-dependent acute myeloid leukemia M-07e through the IL-2 receptor beta/gamma. Int J Cancer. 1998;78:189–195
  19. Huber M, Brüstle A, Reinhard K, et al. IRF4 is essential for IL-21-mediated induction, amplification, and stabilization of the Th17 phenotype. Proc Natl Acad Sci U S A. 2008;105:20846–20851
  20. Rückert R, Bulfone-Paus S, Brandt K. Interleukin-21 stimulates antigen uptake, protease activity, survival and induction of CD4+ T cell proliferation by murine macrophages. Clin Exp Immunol. 2008;151:487–495
  21. Strengell M, Lehtonen A, Matikainen S, Julkunen I. IL-21 enhances SOCS gene expression and inhibits LPS-induced cytokine production in human monocyte-derived dendritic cells. J Leukoc Biol. 2006;79:1279–1285
  22. Buske C, Twiling A, Gogowski G, et al. In vitro activation of low-grade non-Hodgkin's lymphoma by murine fibroblasts, IL-4, anti-CD40 antibodies and the soluble CD40 ligand. Leukemia. 1997;11:1862–1867
  23. Calvo KR, Dabir B, Kovach A, et al. IL-4 protein expression and basal activation of Erk in vivo in follicular lymphoma. Blood. 2008;112:3818–3822
  24. Ratthé C, Girard D. Investigation of the interleukin (IL)-4/IL-4 receptor system in promyelocytic leukaemia PLB-985 cells during differentiation toward neutrophil-like phenotype: mechanism involved in IL-4-induced SOCS3 protein expression. Br J Haematol. 2008;140:59–70
  25. Canfield S, Lee Y, Schroder A, Rothman P. Cutting edge: IL-4 induces suppressor of cytokine signaling-3 expression in B cells by a mechanism dependent on activation of p38 MAPK. J Immunol. 2005;174:2494–2498
  26. Lwin T, Hazlehurst LA, Li Z, et al. Bone marrow stromal cells prevent apoptosis of lymphoma cells by upregulation of anti-apoptotic proteins associated with activation of NF-kappaB (RelB/p52) in non-Hodgkin's lymphoma cells. Leukemia. 2007;21:1521–1531
  27. Russell SM, Tayebi N, Nakajima H, et al. Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development. Science. 1995;270:797–800
  28. Konforte D, Paige CJ. Identification of cellular intermediates and molecular pathways induced by IL21 in human B cells. J Immunol. 2006;177:8381–8392
  29. Sarosiek KA, Malumbres R, Nechushtan H, Gentles AJ, Avisar E, Lossos IS. Novel IL-21 signaling pathway up-regulates c-Myc and induces apoptosis of diffuse large B-cell lymphomas. Blood. 2010;115:570–580
  30. Ghia P, Caligaris-Cappio F. The indispensable role of microenvironment in the natural history of low-grade B-cell neoplasms. Adv Cancer Res. 2000;79:157–173
  31. Küppers R. Prognosis in follicular lymphoma—it's in the microenvironment. N Engl J Med. 2004;351:2152–2153
  32. Kluin-Nelemans HC, Limpens J, Meerabux J, et al. A new non-Hodgkin's B-cell line (DoHH2) with a chromosomal translocation t(14;18)(q32;q21). Leukemia. 1991;5:221–224
  33. Krishnadasan R, Bifulco C, Kim J, Rodov S, Zieske AW, Vanasse GJ. Overexpression of SOCS3 is associated with decreased survival in a cohort of patients with de novo follicular lymphoma. Brit J Haematol. 2006;135:72–75
  34. Robetorye RS, Bohling SD, Morgan JW, Fillmore GC, Lim MS, Elenitoba-Johnson KS. Microarray analysis of B-cell lymphoma cell lines with the t(14;18). J Mol Diagn. 2002;4:123–136
  35. Spolski R, Leonard WJ. IL-21 and follicular helper cells. Int Immunol. 2010;22:7–12

PII: S0301-472X(10)00053-6

doi: 10.1016/j.exphem.2010.02.008

Experimental Hematology
Volume 38, Issue 5 , Pages 373-383 , May 2010

Article Tools

* Image Usage & Resolution